MSOS Long with 150% Upside - Cannabis Rescheduling Catalyst💠 Catalyst : Cannabis is currently classified as a schedule I drug alongside heroin, bath salts, and synthetic opioids that kill thousands every year — all while being safer than Tylenol and legal in over half the country. Cannabis is likely to be rescheduled to a schedule III drug soon after Terry
Key stats
About AdvisorShares Pure US Cannabis ETF
Home page
Inception date
Sep 1, 2020
Structure
Open-Ended Fund
Replication method
Physical
Dividend treatment
Distributes
Distribution tax treatment
Qualified dividends
Income tax type
Capital Gains
Max ST capital gains rate
39.60%
Max LT capital gains rate
20.00%
Primary advisor
AdvisorShares Investments LLC
Distributor
Foreside Fund Services LLC
ISIN
US00768Y4531
MSOS is the first US-listed actively managed ETF to provide exposure solely to American cannabis and hemp companies, including multi-state operators (MSOs). This is the second fund from AdvisorShares dedicated to the cannabis investment strategy. MSOS seeks long-term capital appreciation by investing entirely in legal, domestic cannabis equity securities. Stocks may be of mid- and small-cap companies. In addition, the fund will use total return swap contracts to create such exposure. The fund advisor uses a variety of tools and ratings sources to select securities. Companies must be registered with the DEA specifically for the purpose of handling marijuana for lawful research and development of cannabis or cannabinoid-related products. Stocks selected may focus on areas such as REITs, health care, cannabidiol (CBD), pharmaceutical and hydroponics. In addition to investment risks, investors need to be aware of the ongoing regulatory risks.
Related funds
Classification
What's in the fund
Exposure type
Process Industries
Cash
Mutual fund
Stock breakdown by region
Top 10 holdings
MSOS Long with 150% Upside - Cannabis Rescheduling Catalyst💠 Catalyst: Cannabis is currently classified as a schedule I drug alongside heroin, bath salts, and synthetic opioids that kill thousands every year — all while being safer than Tylenol and legal in over half the country. Cannabis is likely to be rescheduled to a schedule III drug soon after Terry
$MSOS long term buy hereAMEX:MSOS hit my long term downside target yesterday of $2.46 and I entered a starter position down there. It's up 9% today.
There is still the possibility that we get a final capitulation move from here down to $1.55 or so, and if we get it, I'll add a much heavier position. But basically from he
Weed stocks over sold from tax loss harvesting?Ive traded gtbif green thumb successful before and think this might be the time to trade again. Gtbif is one of the biggest holdings inside this Msos etf.
I like the etf MSOS, the shares of GTBIF, and any of the other profitable Cannabis stocks.
Looking for mean reversion, even 2x upside potentia
MSOS the cannabis trade we all need to know about Election Day in Florida is right around the corner, and Amendment 3 has got cannabis investors buzzing. If you're keeping tabs on the market, you've probably noticed MSOS popping up everywhere.
MSOS, short for the AdvisorShares Pure US Cannabis ETF, isn't your average investment fund. It's more lik
Could rally over $11 in 4 to 6 weeks IMHOReclassification is here - it's right around the corner.
Overall, rescheduling ain't gonna do much. It will classify marijuana as a drug that has
potential for abuse, while still being acknowledged for its medicinal benefits.
The kicker though is the tax and banking implications.
1. Reclassify
MSOS Long 7/13/24Anticipating the completion of wave following the development of a diagonal wave .
A rapid impulsive reversal should confirm wave is complete and wave is in progress towards and through 11.37. Alternatively, if price fails to develop in an impulsive manner, it may signal wave is not yet com
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
An exchange-traded fund (ETF) is a collection of assets (stocks, bonds, commodities, etc.) that track an underlying index and can be bought on an exchange like individual stocks.
MSOS assets under management is 912.71 M USD. AUM is an important metric as it reflects the fund's size and can serve as a gauge of how successful the fund is in attracting investors, which, in its turn, can influence decision-making.
Since ETFs work like an individual stock, they can be bought and sold on exchanges (e.g. NASDAQ, NYSE, EURONEXT). As it happens with stocks, you need to select a brokerage to access trading. Explore our list of available brokers to find the one to help execute your strategies. Don't forget to do your research before getting to trading. Explore ETFs metrics in our ETF screener to find a reliable opportunity.
MSOS invests in cash. See more details in our Analysis section.
MSOS expense ratio is 0.77%. It's an important metric for helping traders understand the fund's operating costs relative to assets and how expensive it would be to hold the fund.
No, MSOS isn't leveraged, meaning it doesn't use borrowings or financial derivatives to magnify the performance of the underlying assets or index it follows.
MSOS shares are issued by Wilson Lane Group LLC
MSOS follows the No Underlying Index. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
The fund started trading on Sep 1, 2020.
The fund's management style is active, aiming to outperform its benchmark index by actively selecting and adjusting assets. The goal is to achieve returns that exceed those of the index the fund tracks.